ReviewPatient related outcome measures2019

Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives.

Osman Ozel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.